Russell Kevin Klass serves as Executive at Zomedica Corp., where they oversee executive responsibilities. Since joining the company, Russell Kevin Klass has executed 10 insider transactions totaling $243.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 13, 2025 involved purchasing 150,000 shares valued at $15.0K.
Russell Kevin Klass currently holds 5,784,101 shares of Zomedica Corp. (ZOM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Russell Kevin Klass has been a net buyer of ZOM stock. They have purchased $243.0K and sold $0 worth of shares.
Russell Kevin Klass's most recent insider trade was on Nov 13, 2025, when they purchased 150,000 shares at $0.10 per share.
Get notified when new Form 4 filings are submitted
| $0.10 |
| Discretionary |
| Nov 7, 2025 | ZOMDF | $500 | Purchase | 5,000 | $0.10 | Discretionary |
| Nov 6, 2025 | ZOMDF | $20.2K | Purchase | 253,007 | $0.08 | Discretionary |
| Aug 12, 2025 | ZOMDF | $29.8K | Purchase | 745,341 | $0.04 | Discretionary |
| Aug 12, 2025 | ZOMDF | $10.0K | Purchase | 250,000 | $0.04 | Discretionary |
| Aug 11, 2025 | ZOMDF | $2.4K | Purchase | 60,723 | $0.04 | Discretionary |
| Jun 12, 2024 | ZOM | $48.0K | Purchase | 299,993 | $0.16 | Discretionary |
| Jun 11, 2024 | ZOM | $75.0K | Purchase | 500,000 | $0.15 | Discretionary |
| Jun 10, 2024 | ZOM | $30.0K | Purchase | 200,007 | $0.15 | Discretionary |